Partitioning of pulmonary vascular resistances in group 2 pulmonary hypertension: insightful suggestions for bridging haemodynamics to underlying mechanisms

Marco Guazzi

Source: Eur Respir J, 51 (5) 1800816; 10.1183/13993003.00816-2018

Journal Issue: May

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marco Guazzi. Partitioning of pulmonary vascular resistances in group 2 pulmonary hypertension: insightful suggestions for bridging haemodynamics to underlying mechanisms. Eur Respir J, 51 (5) 1800816; 10.1183/13993003.00816-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

New insights in pulmonary vascular biology and pathophysiology Source: Annual Congress 2006 - Physiological year in review Year: 2006
Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives Source: Eur Respir Rev 2016; 25: 135-140 Year: 2016
Novel treatment for pulmonary vascular disease: lessons from pathophysiology Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006
Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007
Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 526s Year: 2006
Asthma and pulmonary arterial hypertension: Two phenotypes sharing a key underlying mechanism Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010
Novel insights into the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020
Integrating haemodynamics identifies an extreme pulmonary hypertension phenotype Source: Eur Respir J, 58 (2) 2004625; 10.1183/13993003.04625-2020 Year: 2021
Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms Source: Eur Respir Rev, 30 (160) 200284; 10.1183/16000617.0284-2020 Year: 2021
Novel techniques for advancing our understanding of pulmonary arterial hypertension Source: Eur Respir J, 53 (5) 1900556; 10.1183/13993003.00556-2019 Year: 2019
The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations Source: Eur Respir Rev 2014; 23: 350-355 Year: 2014
Pulmonary vascular resistances during exercise in normal subjects: a systematic review Source: Eur Respir J 2012; 39: 319-328 Year: 2012
Mechanisms underlying pulmonary vascular changes in COPD patients Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed Source: Eur Respir J 2010; 36: 986-990 Year: 2010
Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis Source: Eur Respir J 2002; 20: Suppl. 38, 371s Year: 2002
Molecular determinants of cardiac and pulmonary vascular remodeling in scleroderma-related pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases Year: 2008
Pulmonary vascular resistance and compliance relationship in pulmonary hypertension Source: Eur Respir J 2015; 46: 1178-1189 Year: 2015
Towards a molecular classification of pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 987-989 Year: 2016